HEADER TRANSFERASE/TRANSFERASE INHIBITOR 05-JUL-16 5KPP TITLE STRUCTURE OF HUMAN PARP1 CATALYTIC DOMAIN BOUND TO A QUINAZOLINE-2, TITLE 2 4(1H,3H)-DIONE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: POLY [ADP-RIBOSE] POLYMERASE 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CATALYTIC DOMAIN, UNP RESIDUES 662-1011; COMPND 5 SYNONYM: PARP-1,ADP-RIBOSYLTRANSFERASE DIPHTHERIA TOXIN-LIKE 1,ARTD1, COMPND 6 NAD(+) ADP-RIBOSYLTRANSFERASE 1,ADPRT 1,POLY[ADP-RIBOSE] SYNTHASE 1; COMPND 7 EC: 2.4.2.30; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PARP1, ADPRT, PPOL; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS INHIBITOR, COMPLEX, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR R.CAO,Y.L.WANG,J.ZHOU,N.HUANG,B.L.XU REVDAT 2 20-MAR-24 5KPP 1 REMARK REVDAT 1 30-NOV-16 5KPP 0 JRNL AUTH R.CAO,Y.L.WANG,J.ZHOU,N.HUANG,B.L.XU JRNL TITL STRUCTURE OF HUMAN PARP1 CATALYTIC DOMAIN BOUND TO A JRNL TITL 2 QUINAZOLINE-2,4(1H,3H)-DIONE INHIBITOR JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.33 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0123 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.33 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 81.74 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 3 NUMBER OF REFLECTIONS : 30236 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.241 REMARK 3 R VALUE (WORKING SET) : 0.239 REMARK 3 FREE R VALUE : 0.284 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1578 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.33 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.39 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2153 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.89 REMARK 3 BIN R VALUE (WORKING SET) : 0.3040 REMARK 3 BIN FREE R VALUE SET COUNT : 118 REMARK 3 BIN FREE R VALUE : 0.3250 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5490 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 68 REMARK 3 SOLVENT ATOMS : 174 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 48.72 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.50000 REMARK 3 B22 (A**2) : 2.77000 REMARK 3 B33 (A**2) : -3.28000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.515 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.296 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.265 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 11.436 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.929 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.901 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5724 ; 0.007 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 5576 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7734 ; 1.126 ; 1.993 REMARK 3 BOND ANGLES OTHERS (DEGREES): 12902 ; 0.904 ; 3.003 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 698 ; 6.726 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 246 ;35.701 ;25.203 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1062 ;13.980 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 22 ;12.831 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 862 ; 0.067 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 6348 ; 0.004 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 1218 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2804 ; 1.551 ; 4.841 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2803 ; 1.551 ; 4.839 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3498 ; 2.776 ; 7.250 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 3499 ; 2.776 ; 7.252 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2920 ; 1.292 ; 4.953 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 2917 ; 1.292 ; 4.955 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 4234 ; 2.337 ; 7.346 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 6272 ; 4.808 ;36.897 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 6243 ; 4.726 ;36.848 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 5KPP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 11-JUL-16. REMARK 100 THE DEPOSITION ID IS D_1000219749. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-SEP-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL17U REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.987 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : IMOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32359 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.330 REMARK 200 RESOLUTION RANGE LOW (A) : 92.660 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 200 DATA REDUNDANCY : 11.70 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 21.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.73 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.35 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.5M AMMONIUM SULFATE, 100MM TRIS, PH REMARK 280 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.32800 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 81.74350 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 46.34550 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 81.74350 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.32800 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 46.34550 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 724 REMARK 465 SER B 724 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 663 125.24 67.05 REMARK 500 MET A 696 75.83 -118.40 REMARK 500 LYS A 747 -111.79 42.61 REMARK 500 LYS A 748 90.93 51.74 REMARK 500 ASP A 914 62.04 -162.99 REMARK 500 ASP A 981 73.95 -112.03 REMARK 500 SER B 663 127.72 63.10 REMARK 500 SER B 721 30.36 -75.43 REMARK 500 GLN B 722 62.38 -168.22 REMARK 500 LYS B 747 -97.76 66.52 REMARK 500 LYS B 748 70.90 63.20 REMARK 500 THR B 821 48.50 -101.32 REMARK 500 HIS B 826 56.61 -99.70 REMARK 500 ASN B 980 -69.75 -90.74 REMARK 500 LYS B1000 -60.60 -109.69 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 MET A 746 LYS A 747 140.30 REMARK 500 LYS A 747 LYS A 748 -134.70 REMARK 500 GLY B 745 MET B 746 149.44 REMARK 500 MET B 746 LYS B 747 143.54 REMARK 500 LYS B 747 LYS B 748 -145.76 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6WZ A 1101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6WZ B 1101 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5KPN RELATED DB: PDB REMARK 900 RELATED ID: 5KPO RELATED DB: PDB REMARK 900 RELATED ID: 5KPQ RELATED DB: PDB DBREF 5KPP A 662 1011 UNP P09874 PARP1_HUMAN 662 1011 DBREF 5KPP B 662 1011 UNP P09874 PARP1_HUMAN 662 1011 SEQADV 5KPP ALA A 762 UNP P09874 VAL 762 ENGINEERED MUTATION SEQADV 5KPP ALA B 762 UNP P09874 VAL 762 ENGINEERED MUTATION SEQRES 1 A 350 LYS SER LYS LEU PRO LYS PRO VAL GLN ASP LEU ILE LYS SEQRES 2 A 350 MET ILE PHE ASP VAL GLU SER MET LYS LYS ALA MET VAL SEQRES 3 A 350 GLU TYR GLU ILE ASP LEU GLN LYS MET PRO LEU GLY LYS SEQRES 4 A 350 LEU SER LYS ARG GLN ILE GLN ALA ALA TYR SER ILE LEU SEQRES 5 A 350 SER GLU VAL GLN GLN ALA VAL SER GLN GLY SER SER ASP SEQRES 6 A 350 SER GLN ILE LEU ASP LEU SER ASN ARG PHE TYR THR LEU SEQRES 7 A 350 ILE PRO HIS ASP PHE GLY MET LYS LYS PRO PRO LEU LEU SEQRES 8 A 350 ASN ASN ALA ASP SER VAL GLN ALA LYS ALA GLU MET LEU SEQRES 9 A 350 ASP ASN LEU LEU ASP ILE GLU VAL ALA TYR SER LEU LEU SEQRES 10 A 350 ARG GLY GLY SER ASP ASP SER SER LYS ASP PRO ILE ASP SEQRES 11 A 350 VAL ASN TYR GLU LYS LEU LYS THR ASP ILE LYS VAL VAL SEQRES 12 A 350 ASP ARG ASP SER GLU GLU ALA GLU ILE ILE ARG LYS TYR SEQRES 13 A 350 VAL LYS ASN THR HIS ALA THR THR HIS ASN ALA TYR ASP SEQRES 14 A 350 LEU GLU VAL ILE ASP ILE PHE LYS ILE GLU ARG GLU GLY SEQRES 15 A 350 GLU CYS GLN ARG TYR LYS PRO PHE LYS GLN LEU HIS ASN SEQRES 16 A 350 ARG ARG LEU LEU TRP HIS GLY SER ARG THR THR ASN PHE SEQRES 17 A 350 ALA GLY ILE LEU SER GLN GLY LEU ARG ILE ALA PRO PRO SEQRES 18 A 350 GLU ALA PRO VAL THR GLY TYR MET PHE GLY LYS GLY ILE SEQRES 19 A 350 TYR PHE ALA ASP MET VAL SER LYS SER ALA ASN TYR CYS SEQRES 20 A 350 HIS THR SER GLN GLY ASP PRO ILE GLY LEU ILE LEU LEU SEQRES 21 A 350 GLY GLU VAL ALA LEU GLY ASN MET TYR GLU LEU LYS HIS SEQRES 22 A 350 ALA SER HIS ILE SER LYS LEU PRO LYS GLY LYS HIS SER SEQRES 23 A 350 VAL LYS GLY LEU GLY LYS THR THR PRO ASP PRO SER ALA SEQRES 24 A 350 ASN ILE SER LEU ASP GLY VAL ASP VAL PRO LEU GLY THR SEQRES 25 A 350 GLY ILE SER SER GLY VAL ASN ASP THR SER LEU LEU TYR SEQRES 26 A 350 ASN GLU TYR ILE VAL TYR ASP ILE ALA GLN VAL ASN LEU SEQRES 27 A 350 LYS TYR LEU LEU LYS LEU LYS PHE ASN PHE LYS THR SEQRES 1 B 350 LYS SER LYS LEU PRO LYS PRO VAL GLN ASP LEU ILE LYS SEQRES 2 B 350 MET ILE PHE ASP VAL GLU SER MET LYS LYS ALA MET VAL SEQRES 3 B 350 GLU TYR GLU ILE ASP LEU GLN LYS MET PRO LEU GLY LYS SEQRES 4 B 350 LEU SER LYS ARG GLN ILE GLN ALA ALA TYR SER ILE LEU SEQRES 5 B 350 SER GLU VAL GLN GLN ALA VAL SER GLN GLY SER SER ASP SEQRES 6 B 350 SER GLN ILE LEU ASP LEU SER ASN ARG PHE TYR THR LEU SEQRES 7 B 350 ILE PRO HIS ASP PHE GLY MET LYS LYS PRO PRO LEU LEU SEQRES 8 B 350 ASN ASN ALA ASP SER VAL GLN ALA LYS ALA GLU MET LEU SEQRES 9 B 350 ASP ASN LEU LEU ASP ILE GLU VAL ALA TYR SER LEU LEU SEQRES 10 B 350 ARG GLY GLY SER ASP ASP SER SER LYS ASP PRO ILE ASP SEQRES 11 B 350 VAL ASN TYR GLU LYS LEU LYS THR ASP ILE LYS VAL VAL SEQRES 12 B 350 ASP ARG ASP SER GLU GLU ALA GLU ILE ILE ARG LYS TYR SEQRES 13 B 350 VAL LYS ASN THR HIS ALA THR THR HIS ASN ALA TYR ASP SEQRES 14 B 350 LEU GLU VAL ILE ASP ILE PHE LYS ILE GLU ARG GLU GLY SEQRES 15 B 350 GLU CYS GLN ARG TYR LYS PRO PHE LYS GLN LEU HIS ASN SEQRES 16 B 350 ARG ARG LEU LEU TRP HIS GLY SER ARG THR THR ASN PHE SEQRES 17 B 350 ALA GLY ILE LEU SER GLN GLY LEU ARG ILE ALA PRO PRO SEQRES 18 B 350 GLU ALA PRO VAL THR GLY TYR MET PHE GLY LYS GLY ILE SEQRES 19 B 350 TYR PHE ALA ASP MET VAL SER LYS SER ALA ASN TYR CYS SEQRES 20 B 350 HIS THR SER GLN GLY ASP PRO ILE GLY LEU ILE LEU LEU SEQRES 21 B 350 GLY GLU VAL ALA LEU GLY ASN MET TYR GLU LEU LYS HIS SEQRES 22 B 350 ALA SER HIS ILE SER LYS LEU PRO LYS GLY LYS HIS SER SEQRES 23 B 350 VAL LYS GLY LEU GLY LYS THR THR PRO ASP PRO SER ALA SEQRES 24 B 350 ASN ILE SER LEU ASP GLY VAL ASP VAL PRO LEU GLY THR SEQRES 25 B 350 GLY ILE SER SER GLY VAL ASN ASP THR SER LEU LEU TYR SEQRES 26 B 350 ASN GLU TYR ILE VAL TYR ASP ILE ALA GLN VAL ASN LEU SEQRES 27 B 350 LYS TYR LEU LEU LYS LEU LYS PHE ASN PHE LYS THR HET 6WZ A1101 34 HET 6WZ B1101 34 HETNAM 6WZ 1-[[4-FLUORANYL-3-[(3R)-3-METHYL-4-[2,2,2- HETNAM 2 6WZ TRIS(FLUORANYL)ETHYL]PIPERAZIN-1-YL]CARBONYL- HETNAM 3 6WZ PHENYL]METHYL]QUINAZOLINE-2,4-DIONE FORMUL 3 6WZ 2(C23 H22 F4 N4 O3) FORMUL 5 HOH *174(H2 O) HELIX 1 AA1 PRO A 666 PHE A 677 1 12 HELIX 2 AA2 ASP A 678 TYR A 689 1 12 HELIX 3 AA3 PRO A 697 LEU A 701 5 5 HELIX 4 AA4 SER A 702 GLN A 722 1 21 HELIX 5 AA5 ASP A 726 ILE A 740 1 15 HELIX 6 AA6 ASN A 754 GLY A 780 1 27 HELIX 7 AA7 ASP A 788 LEU A 797 1 10 HELIX 8 AA8 SER A 808 THR A 821 1 14 HELIX 9 AA9 ALA A 823 ASN A 827 5 5 HELIX 10 AB1 GLY A 843 LYS A 849 1 7 HELIX 11 AB2 PRO A 850 LYS A 852 5 3 HELIX 12 AB3 ARG A 865 THR A 867 5 3 HELIX 13 AB4 ASN A 868 GLY A 876 1 9 HELIX 14 AB5 PRO A 885 TYR A 889 5 5 HELIX 15 AB6 MET A 900 ASN A 906 1 7 HELIX 16 AB7 TYR A 907 HIS A 909 5 3 HELIX 17 AB8 PRO A 958 ASN A 961 5 4 HELIX 18 AB9 ASP A 993 ALA A 995 5 3 HELIX 19 AC1 PRO B 666 PHE B 677 1 12 HELIX 20 AC2 ASP B 678 TYR B 689 1 12 HELIX 21 AC3 PRO B 697 LEU B 701 5 5 HELIX 22 AC4 SER B 702 SER B 721 1 20 HELIX 23 AC5 ASP B 726 ILE B 740 1 15 HELIX 24 AC6 ASN B 754 ARG B 779 1 26 HELIX 25 AC7 ASP B 788 LYS B 798 1 11 HELIX 26 AC8 SER B 808 THR B 821 1 14 HELIX 27 AC9 GLY B 843 LYS B 849 1 7 HELIX 28 AD1 PRO B 850 LYS B 852 5 3 HELIX 29 AD2 ARG B 865 THR B 867 5 3 HELIX 30 AD3 ASN B 868 GLY B 876 1 9 HELIX 31 AD4 PRO B 885 TYR B 889 5 5 HELIX 32 AD5 MET B 900 TYR B 907 1 8 HELIX 33 AD6 ASP B 993 ALA B 995 5 3 SHEET 1 AA1 5 THR A 799 VAL A 803 0 SHEET 2 AA1 5 TYR A 829 ARG A 841 -1 O LYS A 838 N LYS A 802 SHEET 3 AA1 5 VAL A 997 PHE A1009 -1 O LEU A1002 N PHE A 837 SHEET 4 AA1 5 ILE A 916 ALA A 925 -1 N GLU A 923 O ASN A 998 SHEET 5 AA1 5 ARG A 857 SER A 864 -1 N HIS A 862 O LEU A 920 SHEET 1 AA2 4 ILE A 895 PHE A 897 0 SHEET 2 AA2 4 GLU A 988 VAL A 991 -1 O TYR A 989 N PHE A 897 SHEET 3 AA2 4 SER A 947 GLY A 950 -1 N GLY A 950 O GLU A 988 SHEET 4 AA2 4 MET A 929 LEU A 932 1 N TYR A 930 O SER A 947 SHEET 1 AA3 3 GLY A 974 SER A 976 0 SHEET 2 AA3 3 GLY A 952 PRO A 956 -1 N THR A 955 O ILE A 975 SHEET 3 AA3 3 LEU A 984 TYR A 986 1 O LEU A 985 N THR A 954 SHEET 1 AA4 2 ILE A 962 LEU A 964 0 SHEET 2 AA4 2 VAL A 967 VAL A 969 -1 O VAL A 969 N ILE A 962 SHEET 1 AA5 5 THR B 799 VAL B 803 0 SHEET 2 AA5 5 TYR B 829 ARG B 841 -1 O LYS B 838 N LYS B 802 SHEET 3 AA5 5 VAL B 997 PHE B1009 -1 O LYS B1000 N ILE B 839 SHEET 4 AA5 5 ILE B 916 ALA B 925 -1 N GLU B 923 O ASN B 998 SHEET 5 AA5 5 ARG B 857 SER B 864 -1 N ARG B 858 O VAL B 924 SHEET 1 AA6 4 ILE B 895 PHE B 897 0 SHEET 2 AA6 4 GLU B 988 VAL B 991 -1 O TYR B 989 N PHE B 897 SHEET 3 AA6 4 SER B 947 GLY B 950 -1 N GLY B 950 O GLU B 988 SHEET 4 AA6 4 MET B 929 LEU B 932 1 N TYR B 930 O SER B 947 SHEET 1 AA7 2 THR B 954 PRO B 956 0 SHEET 2 AA7 2 GLY B 974 SER B 976 -1 O ILE B 975 N THR B 955 SHEET 1 AA8 2 ASN B 961 SER B 963 0 SHEET 2 AA8 2 ASP B 968 PRO B 970 -1 O VAL B 969 N ILE B 962 SITE 1 AC1 17 ASP A 766 LEU A 769 HIS A 862 GLY A 863 SITE 2 AC1 17 ARG A 878 ILE A 879 ALA A 880 TYR A 889 SITE 3 AC1 17 GLY A 894 ILE A 895 TYR A 896 PHE A 897 SITE 4 AC1 17 SER A 904 TYR A 907 GLU A 988 HOH A1230 SITE 5 AC1 17 HOH A1233 SITE 1 AC2 15 ASP B 766 LEU B 769 ASP B 770 HIS B 862 SITE 2 AC2 15 GLY B 863 ARG B 878 ALA B 880 TYR B 889 SITE 3 AC2 15 GLY B 894 ILE B 895 TYR B 896 PHE B 897 SITE 4 AC2 15 SER B 904 TYR B 907 GLU B 988 CRYST1 48.656 92.691 163.487 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020552 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010789 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006117 0.00000